Literature DB >> 23519210

Structural basis for molecular recognition at serotonin receptors.

Chong Wang1, Yi Jiang, Jinming Ma, Huixian Wu, Daniel Wacker, Vsevolod Katritch, Gye Won Han, Wei Liu, Xi-Ping Huang, Eyal Vardy, John D McCorvy, Xiang Gao, X Edward Zhou, Karsten Melcher, Chenghai Zhang, Fang Bai, Huaiyu Yang, Linlin Yang, Hualiang Jiang, Bryan L Roth, Vadim Cherezov, Raymond C Stevens, H Eric Xu.   

Abstract

Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiology through the 5-HT receptor family. We report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine. The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops. The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT. Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity. Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519210      PMCID: PMC3644373          DOI: 10.1126/science.1232807

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

Review 2.  Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

3.  Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.

Authors:  Vincent Setola; Malgorzata Dukat; Richard A Glennon; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2005-04-14       Impact factor: 4.436

4.  Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.

Authors:  D A Shapiro; K Kristiansen; W K Kroeze; B L Roth
Journal:  Mol Pharmacol       Date:  2000-11       Impact factor: 4.436

Review 5.  Migraine: pathophysiology, pharmacology, treatment and future trends.

Authors:  Carlos M Villalón; David Centurión; Luis Felipe Valdivia; Peter de Vries; Pramod R Saxena
Journal:  Curr Vasc Pharmacol       Date:  2003-03       Impact factor: 2.719

6.  Pharmaceutical approval update.

Authors:  Marvin M Goldenberg
Journal:  P T       Date:  2012-09

Review 7.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

8.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

Review 9.  Molecular biology of serotonin receptors structure and function at the molecular level.

Authors:  Wesley K Kroeze; Kurt Kristiansen; Bryan L Roth
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

10.  Automated design of ligands to polypharmacological profiles.

Authors:  Jérémy Besnard; Gian Filippo Ruda; Vincent Setola; Keren Abecassis; Ramona M Rodriguiz; Xi-Ping Huang; Suzanne Norval; Maria F Sassano; Antony I Shin; Lauren A Webster; Frederick R C Simeons; Laste Stojanovski; Annik Prat; Nabil G Seidah; Daniel B Constam; G Richard Bickerton; Kevin D Read; William C Wetsel; Ian H Gilbert; Bryan L Roth; Andrew L Hopkins
Journal:  Nature       Date:  2012-12-13       Impact factor: 49.962

View more
  156 in total

1.  Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor.

Authors:  Márton Vass; Balázs Jójárt; Ferenc Bogár; Gábor Paragi; György M Keserű; Ákos Tarcsay
Journal:  J Comput Aided Mol Des       Date:  2015-11-16       Impact factor: 3.686

Review 2.  Tuning up the right signal: chemical and genetic approaches to study GPCR functions.

Authors:  Patrick M Giguere; Wesley K Kroeze; Bryan L Roth
Journal:  Curr Opin Cell Biol       Date:  2013-12-08       Impact factor: 8.382

3.  Global fold of human cannabinoid type 2 receptor probed by solid-state 13C-, 15N-MAS NMR and molecular dynamics simulations.

Authors:  Tomohiro Kimura; Krishna Vukoti; Diane L Lynch; Dow P Hurst; Alan Grossfield; Michael C Pitman; Patricia H Reggio; Alexei A Yeliseev; Klaus Gawrisch
Journal:  Proteins       Date:  2013-10-17

4.  Hydrogen/Deuterium Exchange Mass Spectrometry of Human Green Opsin Reveals a Conserved Pro-Pro Motif in Extracellular Loop 2 of Monostable Visual G Protein-Coupled Receptors.

Authors:  Lukas Hofmann; Nathan S Alexander; Wenyu Sun; Jianye Zhang; Tivadar Orban; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2017-04-21       Impact factor: 3.162

Review 5.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 6.  GPCR activation: protonation and membrane potential.

Authors:  Xuejun C Zhang; Kening Sun; Laixing Zhang; Xuemei Li; Can Cao
Journal:  Protein Cell       Date:  2013-09-20       Impact factor: 14.870

7.  Structural basis of G protein-coupled receptor-Gi protein interaction: formation of the cannabinoid CB2 receptor-Gi protein complex.

Authors:  Jagjeet S Mnpotra; Zhuanhong Qiao; Jian Cai; Diane L Lynch; Alan Grossfield; Nicholas Leioatts; Dow P Hurst; Michael C Pitman; Zhao-Hui Song; Patricia H Reggio
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

8.  G protein-coupled receptors: the evolution of structural insight.

Authors:  Samantha B Gacasan; Daniel L Baker; Abby L Parrill
Journal:  AIMS Biophys       Date:  2017-08-21

9.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

10.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.